MedTrace Logo

A Study to Evaluate Microneedle-based Collection of Dermal Interstitial Skin Fluid in Healthy Participants and Atopic Dermatitis Participants

NCT06934980 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2026-01-16

No results posted yet for this study

Summary

The purpose of this study is to evaluate microneedle-based collection of dermal interstitial skin fluid (dISF) in healthy participants and atopic dermatitis (AD) participants

Conditions

Interventions

DEVICE

Microneedle Device

Microneedle device will be used for collecting dermal interstitial skin fluid samples as defined by the protocol.

Sponsors & Collaborators

Principal Investigators

  • Incyte Medical Monitor · Incyte Corporation

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-27
Primary Completion
2025-12-19
Completion
2025-12-19
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06934980 on ClinicalTrials.gov